The ProMetic Life Sciences Inc. (PLI) Receives Consensus Recommendation of “Buy” from the Brokerages - DailyQuint
The ProMetic Life Sciences Inc. (PLI) Receives Consensus Recommendation of “Buy” from the Brokerages – DailyQuint
[ad_1]
ProMetic Life Sciences Inc. (TSE:PLI) has been given a consensus rating of “Buy” by the nine research firms that are currently covering the stock. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is C$4.86.
A number…
View On WordPress











